Human iPSC banking: Barriers and opportunities

132Citations
Citations of this article
327Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The introduction of induced pluripotent stem cells (iPSCs) has opened up the potential for personalized cell therapies and ushered in new opportunities for regenerative medicine, disease modeling, iPSC-based drug discovery and toxicity assessment. Over the past 10 years, several initiatives have been established that aim to collect and generate a large amount of human iPSCs for scientific research purposes. In this review, we compare the construction and operation strategy of some iPSC banks as well as their ongoing development. We also introduce the technical challenges and offer future perspectives pertaining to the establishment and management of iPSC banks.

Cite

CITATION STYLE

APA

Huang, C. Y., Liu, C. L., Ting, C. Y., Chiu, Y. T., Cheng, Y. C., Nicholson, M. W., & Hsieh, P. C. H. (2019, October 28). Human iPSC banking: Barriers and opportunities. Journal of Biomedical Science. BioMed Central Ltd. https://doi.org/10.1186/s12929-019-0578-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free